![BioVie Inc. logo](/logos/BIVI.webp)
BioVie Inc.
NASDAQ:BIVI
Overview | Financials
Company Name | BioVie Inc. |
Symbol | BIVI |
Currency | USD |
Price | 2.49 |
Market Cap | 15,230,210 |
Dividend Yield | 0% |
52-week-range | 2.07 - 58.2 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Cuong Viet Do M.B.A., MBA |
Website | https://bioviepharma.com |
An error occurred while fetching data.
About BioVie Inc.
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD